The Enhancer of Rudimentary Homolog (ERH) protein plays a multifaceted role in cellular processes, including RNA splicing, cell cycle progression, and the regulation of transcription. As a conserved protein across eukaryotes, ERH's function is pivotal in maintaining cellular homeostasis and facilitating the precise execution of genetic programs. Its involvement in critical pathways underscores the importance of ERH in developmental processes, DNA repair mechanisms, and the regulation of gene expression. The protein's ability to interact with various components of the spliceosome and transcription complexes highlights its role as a regulatory hub, influencing the efficiency and specificity of gene expression. Through these interactions, ERH exerts its influence on the splicing of pre-mRNA, contributing to the diversity of mRNA transcripts and the proper synthesis of proteins crucial for cellular function and adaptation to environmental cues.
The inhibition of ERH disrupts these essential cellular processes, leading to alterations in gene expression patterns, potential errors in RNA splicing, and aberrations in cell cycle regulation. Mechanistically, inhibition can be achieved through direct interaction with ERH by molecules that block its active sites or interfere with its ability to form complexes with other proteins. Additionally, post-translational modifications of ERH, such as phosphorylation or ubiquitination, could modulate its activity and stability, thereby serving as indirect methods of inhibition. Genetic downregulation or the use of small interfering RNAs (siRNAs) to decrease ERH levels in the cell can also result in diminished function, further illustrating the variety of mechanisms through which ERH activity can be modulated. Understanding the intricate mechanisms of ERH inhibition is crucial for deciphering its role in cellular physiology and the potential consequences of its dysregulation, which could contribute to the development of diseases or the emergence of cellular dysfunction.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent kinase inhibitor that can affect various signaling pathways, potentially altering ERH function due to its role in cell cycle regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that might affect ERH indirectly by modulating PI3K/Akt signaling, which is related to cell proliferation and survival. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An MEK inhibitor which can influence ERH function by altering the MAPK/ERK pathway, often involved in cell growth and differentiation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can affect transcription factors and, by extension, potentially influence ERH's regulatory functions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor that might alter the stress response pathways and thus affect ERH's role within these pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor similar to LY294002 that can indirectly influence ERH activity through PI3K/Akt signaling alterations. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor which can affect ERH by modulating cell growth and proliferation signaling pathways. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
A Hedgehog signaling pathway inhibitor that might affect ERH indirectly by impacting cellular differentiation processes. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that can affect various cellular processes, potentially disturbing ERH's regulatory roles. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
An HDAC inhibitor that might influence ERH function by altering chromatin structure and gene expression. |